4.7 Article

Do patients with type 2 diabetes have impaired hip bone microstructure? A study using 3D modeling of hip dual-energy X-ray absorptiometry

期刊

FRONTIERS IN ENDOCRINOLOGY
卷 13, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fendo.2022.1069224

关键词

type 2 diabetes mellitus; 3D-DXA; bone modelling; bone remodeling; bone QCT; microCT

向作者/读者索取更多资源

A study found that patients with type 2 diabetes have a higher risk of bone fractures, but conventional DXA is not useful for identifying this risk. This study aims to evaluate 3D-DXA parameters for determining cortical and trabecular compartments in these patients and identify their determinants.
AimPatients with type 2 diabetes (T2DM) have more risk of bone fractures. However, areal bone mineral density (aBMD) by conventional dual-energy x-ray absorptiometry (DXA) is not useful for identifying this risk. This study aims to evaluate 3D-DXA parameters determining the cortical and trabecular compartments in patients with T2DM compared to non-diabetic subjects and to identify their determinants. Materials and methodsCase-control study in 111 T2DM patients (65.4 +/- 7.6 years old) and 134 non-diabetic controls (64.7 +/- 8.6-year-old). DXA, 3D-DXA modelling via 3D-Shaper software and trabecular bone score (TBS) were used to obtain aBMD, cortical and trabecular parameters, and lumbar spine microarchitecture, respectively. In addition, biochemical markers as 25-hydroxyvitamin d, type I procollagen N-terminal propeptide (P1NP), C-terminal telopeptide of type I collagen (CTX), and glycated haemoglobin (HbA1c) were analysed. ResultsMean-adjusted values showed higher aBMD (5.4%-7.7%, ES: 0.33-0.53) and 3D-DXA parameters (4.1%-10.3%, ES: 0.42-0.68) in the T2DM group compared with the control group. However, TBS was lower in the T2DM group compared to the control group (-14.7%, ES: 1.18). In addition, sex (beta = 0.272 to 0.316) and body mass index (BMI) (beta = 0.236 to 0.455) were the most consistent and positive predictors of aBMD (p <= 0.01). BMI and P1NP were negative predictors of TBS (beta = -0.530 and -0.254, respectively, p <= 0.01), while CTX was a positive one (beta = 0.226, p=0.02). Finally, BMI was consistently the strongest positive predictor of 3D-DXA parameters (beta = 0.240 to 0.442, p<0.05). ConclusionPatients with T2DM present higher bone mass measured both by conventional DXA and 3D-DXA, suggesting that 3D-DXA technology is not capable of identifying alterations in bone structure in this population. Moreover, BMI was the most consistent determinant in all bone outcomes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据